Sizes of liver and gallbladder lesions at 7 days after the ablation (X̅± s)
| Ablation | Major diameter of liver lesions (cm) | Gallbladder lesions | |||
|---|---|---|---|---|---|
| methods | Gallbladder side (n = 12) | Diaphragm side (n = 12) | P value | Major diameter (cm) | P value |
| Cryo | 1.5 ± 0.4 | 3.8 ± 0.8 | > 0.05 | 1.5 ± 0.4 (n = 8) | > 0.05 |
| IRE | 1.4 ± 0.4 | 4.1 ± 0.7 | > 0.05 | 0.8 ± 0.2 (n = 12) | |
Changes in aminotransferase and serum bilirubin levels over time (X̅± s)
| Hepatic function | Ablation method | d-1 | d-1 | d-3 | d-5 | d-7 |
|---|---|---|---|---|---|---|
| ALT | RE | 38.35 ± 3.22 | 167.05 ± 19.50 | 214.83 ± 10.37 | 119.60 ± 12.99 | 68.25 ± 10.08 |
| Cryo | 39.20 ± 3.90 | 195.03 ± 9.75 P < 0.01, compared with the IRE group | 289.58 ± 12.81 P < 0.01, compared with the IRE group | 142.35 ± 57.85 P < 0.05 | 94.90 ± 9.78 P < 0.05 | |
| AST(U/L) | IRE | 34.10 ± 0.86 | 47.64 ± 0.69 | 60.21 ± 2.55 | 46.78 ± 1.71 | 31.05 ± 0.43 |
| Cryo | 35.26 ± 2.45 | 60.11 ± 3.44 P < 0.01, compared with the IRE group | 79.12 ± 2.58 P < 0.01, compared with the IRE group | 52.80 ± 3.41 P < 0.05 | 37.41 ± 2.50 P < 0.05 | |
| Serum bilirubin | RE | 8.08 ± 2.19 | 26.01 ± 3.68 | 35.15 ± 5.70 | 29.09 ± 3.27 | 21.41 ± 3.39 |
| Cryo | 7.59 ± 2.01 | 32.72 ± 4.08 P < 0.01, compared with the IRE group | 37.34 ± 6.14 P < 0.05 | 35.88 ± 4.28 P < 0.01, compared with the IRE group | 25.86 ± 5.37 P < 0.05 |